Tumor antigen peptides originating in cyclophilin B

Details Tumor antigen peptides originating in cyclophilin B Tumor antigen peptides originating in cyclophilin B

2006-05-09

2006-05-09

Yu, Misook (Department: 1642)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C530S300000

Reexamination Certificate

active

07041297

ABSTRACT:
Tumor antigen peptides derived from cyclophilins or derivatives thereof having the functionally equivalent properties; medicaments, prophylactics, or diagnostics for tumors comprising as an active ingredient such tumor antigen peptides or derivatives thereof, cyclophilins or partial polypeptides thereof, or genes encoding said cyclophilins or partial polypeptides thereof; in vitro use of the above substances for treatment of tumors; and antibodies against the above tumor antigen peptides derived from cyclophilins or derivatives thereof are provided.

REFERENCES:
patent: 5837248 (1998-11-01), Kikuchi et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 0 326 067 (1989-08-01), None
patent: 0 326 067 (1989-08-01), None
patent: WO94/03205 (1994-02-01), None
Shichijo, et al., 1998, J Exp. Med., 187 (3):277-88.
Burgess et al., J of Cell Bio. 111:2129-2138, 1990.
Lazar et al. Molecular and Cellular Biology 8:1247-1252, 1988.
Bowie et al. Science, 247:1306-1310, 1990.
Riott et al (Immunology, Fourth Edition, 1996, Mosby, p. 7.9-7.11).
Sherman, LA et al. 1998, Critical reviews in Immunol, 18(1-2): 47-54).
Lauritzsen et al (International Journal of Cancer, 1998, vol. 78, pp. 216-222).
Sarma et al (Journal of Experimental Medicine, 1999, vol. 189, pp. 811-820).
Shichijo et al.,J. Exp. Med., vol. 187, No. 3, pp. 277-288 (1998).
Gohara et al.,Jpn. J. Cancer Res., vol. 88, pp. 198-402 (1997).
DNA Researh 2, pp. 167-174 (1995).
Yotnda et al.,J. Clin. Invest., vol. 102, No. 2, pp. 455-462 (1998).
Takahashi et al.,Cellular Immunology, vol. 178, pp. 162-171 (1997).
KIAA0156 (Genbank Accession No. D63879).
HLA-A2 cDNA (Genbank Accession No. M84379).
Thomson et al.,The Journal of Immunology, vol. 160, pp. 1717-1723 (1998).
Proc. Natl. Acad. Sci., USA, vol. 88, pp. 1903-1907 (1991) ; E.R. Price et al.
Immunogenetics, vol. 41, pp. 178-228 (1995) ; H.-G. Rammensee et al.
Biochemistry, vol. 33, pp. 8218-8224 (1994) ; H. Schneider et al.
Journal of Immunology, vol. 152, pp. 3913 (1994) ; Ralph T. Kubo et al.
Journal of Immunology, vol. 154, pp. 2257-2265 (1995) ; L. Rivoltini et al.
Journal of Immunology, vol. 155, pp. 4307-4312 (1995) ; A. Kondo et al.
Journal of Immunology, vol. 155, pp. 4749-4756 (1995) ; T. Sudo et al.
Int.J.Cancer, vol. 58, pp. 317-323 (1994) ; D.D. Kharkevitch et al.
Cancer Research, vol. 55, pp. 4248-4252 (1995) ; M. Nakao et al.
Journal of Immunology, vol. 158, pp. 1796-1802 (1997) ; Van Tsai et al.
J.Natl.Cancer Inst., vol. 86, No. 15, pp. 1159-1166 (1994) ;Steven A. Rosenberg et al.
Science, vol. 274, pp. 94-96 (1996) ; John D. Altman et al.
Lontung Chao et al., Journal of Investigative Dermatology, vol. 102, No. 4, (1994), p. 589, XP001033799.
G. Alkhatib et al., Immunology, vol. 92, No. 2, (1997), pp. 173-179, XP001033900.
Shinya Gomi et al., Journal of Immunology, vol. 163, (1999), pp. 4994-5004, XP002948569.
Price et al., Proc. Natl. Acad. Sci., vol. 88, No. 5, pp. 1903-1907 (1991).
Rammensee et al., Immunogenetics, vol. 41, pp. 178-228 (1995).

Affiliated with

Also associated with

Rating

Tumor antigen peptides originating in cyclophilin B does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor antigen peptides originating in cyclophilin B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor antigen peptides originating in cyclophilin B will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3618879